PRMT6 and breast carcinoma: However, only a minority of the PRMT6-dependent transcriptional and splicing targets overlap, suggesting no generally simultaneous control of both processes by PRMT6 in NT2/D1 cells, in contrast to results received in breast cancer cells (Dowhan et al, 2012).